Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...
The mice model technologies market offers significant opportunities driven by advancements in genetic engineering, particularly CRISPR/Cas9, fueling drug discovery in oncology, neurobiology, and ...
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.
ProvenBase, an AI-powered talent intelligence platform, today announced the addition of globally recognized talent acquisition expert Shally Steckerl to its advisory board, concurrent with the company ...
Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...
Constative on MSN
Weird science studies that ended up being useful
Science isn’t always serious. Sometimes researchers ask questions that seem silly at first, like why toast lands butter-side ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results